Nasdaq Stockholm

The Board of Loomis has resolved to repurchase shares

Retrieved on: 
Tuesday, January 30, 2024

STOCKHOLM, Jan. 30, 2024 /PRNewswire/ -- The Board of Directors of Loomis AB has resolved to repurchase shares by virtue of the authorization granted by the annual general meeting 2023.

Key Points: 
  • STOCKHOLM, Jan. 30, 2024 /PRNewswire/ -- The Board of Directors of Loomis AB has resolved to repurchase shares by virtue of the authorization granted by the annual general meeting 2023.
  • The repurchase may commence on February 1, 2024, end not later than on April 5, 2024, and comprise an amount up to a maximum of SEK 200 million.
  • Danske Bank A/S, Danmark, Sverige Filial will administrate the repurchase and based on the trading order given by Loomis, take trading decisions independently of Loomis with regards to the timing of the acquisitions.
  • The total number of shares in Loomis, including the company's own shares, amounts to 75,279,829.

Millicom (Tigo) share repurchase activity

Retrieved on: 
Friday, January 26, 2024

All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.

Key Points: 
  • All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.
  • Following the purchases, Millicom holds 1,113,026 treasury shares as of January 26, 2024.
  • The repurchase program is being executed consistent with the provisions of Article 5 of MAR and the Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”).
  • For information about all transactions carried out under the repurchase program, refer to Nasdaq Stockholm’s website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/s...

Millicom (Tigo) share repurchase activity

Retrieved on: 
Friday, January 19, 2024

All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.

Key Points: 
  • All purchases were carried out on Nasdaq Stockholm by Citigroup Global Markets Limited on behalf of Millicom.
  • Following the purchases, Millicom holds 877,254 treasury shares as of January 19, 2024.
  • The repurchase program is being executed consistent with the provisions of Article 5 of MAR and the Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”).
  • For information about all transactions carried out under the repurchase program, refer to Nasdaq Stockholm’s website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/s...

Invitation: Sobi's Q4 and FY 2023 report

Retrieved on: 
Wednesday, January 24, 2024

Sobi plans to publish its report for the fourth quarter and full year of 2023 on 8 February 2024 at 08:00 CET.

Key Points: 
  • Sobi plans to publish its report for the fourth quarter and full year of 2023 on 8 February 2024 at 08:00 CET.
  • The presentation can be followed live here or afterwards on sobi.com .
  • The slides will be made available on sobi.com before the conference call.
  • For details on how to contact the Sobi Investor Relations Team, please click here .

Medivir to present at the Redeye Fight Cancer Day

Retrieved on: 
Wednesday, January 24, 2024

STOCKHOLM, Jan. 24, 2024 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day, today January 24, 2024.

Key Points: 
  • STOCKHOLM, Jan. 24, 2024 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day, today January 24, 2024.
  • CEO Jens Lindberg will present the company and updated data from the ongoing phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) at 15.20 CET.
  • Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high.
  • Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a pro-drug designed to selectively treat liver cancer and to minimize side effects.

Stena Sessan AB requests compulsory buy-out and Concordia Maritime applies for delisting

Retrieved on: 
Tuesday, January 23, 2024

GOTHENBURG, Sweden, Jan. 23, 2024 /PRNewswire/ -- Stena Sessan AB ('Stena Sessan'), which holds more than 90 per cent of the shares and votes in Concordia Maritime AB (publ) ('Concordia Maritime'), has requested that a compulsory buy-out of the remaining shares in Concordia Maritime be initiated.

Key Points: 
  • GOTHENBURG, Sweden, Jan. 23, 2024 /PRNewswire/ -- Stena Sessan AB ('Stena Sessan'), which holds more than 90 per cent of the shares and votes in Concordia Maritime AB (publ) ('Concordia Maritime'), has requested that a compulsory buy-out of the remaining shares in Concordia Maritime be initiated.
  • Against the above background, the Board of Directors of Concordia Maritime has decided to apply for delisting of Concordia Maritime's class B shares from Nasdaq Stockholm.
  • This information is information that Concordia Maritime AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
  • Chairman of the Board of Directors, Concordia Maritime AB

Stena Sessan AB requests compulsory buy-out and Concordia Maritime applies for delisting

Retrieved on: 
Tuesday, January 23, 2024

GOTHENBURG, Sweden, Jan. 23, 2024 /PRNewswire/ -- Stena Sessan AB ('Stena Sessan'), which holds more than 90 per cent of the shares and votes in Concordia Maritime AB (publ) ('Concordia Maritime'), has requested that a compulsory buy-out of the remaining shares in Concordia Maritime be initiated.

Key Points: 
  • GOTHENBURG, Sweden, Jan. 23, 2024 /PRNewswire/ -- Stena Sessan AB ('Stena Sessan'), which holds more than 90 per cent of the shares and votes in Concordia Maritime AB (publ) ('Concordia Maritime'), has requested that a compulsory buy-out of the remaining shares in Concordia Maritime be initiated.
  • Against the above background, the Board of Directors of Concordia Maritime has decided to apply for delisting of Concordia Maritime's class B shares from Nasdaq Stockholm.
  • This information is information that Concordia Maritime AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
  • Chairman of the Board of Directors, Concordia Maritime AB

Statement by the Board of Directors [1] of Kindred in relation to the public offer from La Française des Jeux

Retrieved on: 
Monday, January 22, 2024

SLIEMA, Malta., Jan. 22, 2024 /PRNewswire/ -- This statement is made by the Board of Directors (the 'Board') of Kindred Group plc ('Kindred' or the 'Company') pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the 'Takeover Rules').

Key Points: 
  • The Board of Directors of Kindred unanimously recommends the shareholders of Kindred to accept the public offer from La Française des Jeux SA of SEK 130 in cash per share.
  • no information made public by Kindred or disclosed by Kindred to FDJ being materially inaccurate, incomplete or misleading, and Kindred having made public all information which should have been made public by Kindred; and
    viii.
  • no other party announcing an offer to acquire shares or SDRs in Kindred on terms more favourable to the shareholders of Kindred than the Offer.
  • This disclosure contains information that Kindred Group is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).

Statement by the Board of Directors [1] of Kindred in relation to the public offer from La Française des Jeux

Retrieved on: 
Monday, January 22, 2024

SLIEMA, Malta., Jan. 22, 2024 /PRNewswire/ -- This statement is made by the Board of Directors (the 'Board') of Kindred Group plc ('Kindred' or the 'Company') pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the 'Takeover Rules').

Key Points: 
  • The Board of Directors of Kindred unanimously recommends the shareholders of Kindred to accept the public offer from La Française des Jeux SA of SEK 130 in cash per share.
  • no information made public by Kindred or disclosed by Kindred to FDJ being materially inaccurate, incomplete or misleading, and Kindred having made public all information which should have been made public by Kindred; and
    viii.
  • no other party announcing an offer to acquire shares or SDRs in Kindred on terms more favourable to the shareholders of Kindred than the Offer.
  • This disclosure contains information that Kindred Group is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).

NOTICE IS HEREBY GIVEN that THE EXTRAORDINARY GENERAL MEETING ("EGM") of Kindred Group plc

Retrieved on: 
Monday, January 22, 2024

SLIEMA, Malta, Jan. 22, 2024 /PRNewswire/ -- NOTICE IS HEREBY GIVEN that THE EXTRAORDINARY GENERAL MEETING ("EGM") of Kindred Group plc (C 39017) (the "Company") convened in terms of article 135 (1)(b) of the Companies Act (Cap.

Key Points: 
  • SLIEMA, Malta, Jan. 22, 2024 /PRNewswire/ -- NOTICE IS HEREBY GIVEN that THE EXTRAORDINARY GENERAL MEETING ("EGM") of Kindred Group plc (C 39017) (the "Company") convened in terms of article 135 (1)(b) of the Companies Act (Cap.
  • Please note that SDR holders cannot exercise their voting rights via these channels, they are for support purposes only.
  • the updating of details set out in the Memorandum of Association for the purpose of reflecting information filed with the Malta Business Registry.
  • The Directors therefore recommend that the shareholders vote in favour of the said resolution at the forthcoming EGM.